These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32687767)

  • 1. Insights into amyotrophic lateral sclerosis linked Pro525Arg mutation in the fused in sarcoma protein through
    Chatterjee S; Salimi A; Lee JY
    J Biomol Struct Dyn; 2021 Oct; 39(16):5963-5976. PubMed ID: 32687767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study.
    Swetha RG; Ramaiah S; Anbarasu A
    J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
    Basu S; Rajendra KC; Alagar S; Bahadur RP
    Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS.
    Niu C; Zhang J; Gao F; Yang L; Jia M; Zhu H; Gong W
    PLoS One; 2012; 7(10):e47056. PubMed ID: 23056579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS).
    Zhang ZC; Chook YM
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12017-21. PubMed ID: 22778397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6.
    Kamaraj B; Rajendran V; Sethumadhavan R; Kumar CV; Purohit R
    J Biomol Struct Dyn; 2015; 33(4):834-44. PubMed ID: 24738488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics and protein frustration analysis of human fused in Sarcoma protein variants in Amyotrophic Lateral Sclerosis type 6: An In Silico approach.
    Bonet LFS; Loureiro JP; Pereira GRC; Da Silva ANR; De Mesquita JF
    PLoS One; 2021; 16(9):e0258061. PubMed ID: 34587215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
    Wang T; Jiang X; Chen G; Xu J
    Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
    Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
    Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
    Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
    Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
    Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
    EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.
    Kent L; Vizard TN; Smith BN; Topp SD; Vance C; Gkazi A; Miller J; Shaw CE; Talbot K
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):557-62. PubMed ID: 24899262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis.
    Sabatelli M; Moncada A; Conte A; Lattante S; Marangi G; Luigetti M; Lucchini M; Mirabella M; Romano A; Del Grande A; Bisogni G; Doronzio PN; Rossini PM; Zollino M
    Hum Mol Genet; 2013 Dec; 22(23):4748-55. PubMed ID: 23847048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome wide array analysis indicates that an amyotrophic lateral sclerosis mutation of FUS causes an early increase of CAMK2N2 in vitro.
    Convertini P; Zhang J; de la Grange P; Hayward LJ; Zhu H; Stamm S
    Biochim Biophys Acta; 2013 Aug; 1832(8):1129-35. PubMed ID: 23545117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.
    Nomura T; Watanabe S; Kaneko K; Yamanaka K; Nukina N; Furukawa Y
    J Biol Chem; 2014 Jan; 289(2):1192-202. PubMed ID: 24280224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.